According to Ascendis Pharma 's latest financial reports the company's current earnings (TTM) are -$0.41 B. In 2022 the company made an earning of -$0.53 B a decrease over its 2021 earnings that were of -$0.43 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.46 B | -13.72% |
2022 | -$0.53 B | 23.17% |
2021 | -$0.43 B | -10.38% |
2020 | -$0.48 B | 104.57% |
2019 | -$0.24 B | 61.23% |
2018 | -$0.15 B | 0.79% |
2017 | -$0.15 B | 90.02% |
2016 | -$75.84 M | 103.21% |
2015 | -$37.33 M | 186.25% |
2014 | -$13.04 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Akebia Therapeutics AKBA | -$51.27 M | -87.28% | ๐บ๐ธ USA |
Affimed
AFMD | -$0.12 B | -71.48% | ๐ฉ๐ช Germany |
Advaxis ADXS | -$34.03 M | -91.55% | ๐บ๐ธ USA |